Literature DB >> 14557672

Induction of protective immunity against malaria by priming-boosting immunization with recombinant cold-adapted influenza and modified vaccinia Ankara viruses expressing a CD8+-T-cell epitope derived from the circumsporozoite protein of Plasmodium yoelii.

Gloria González-Aseguinolaza1, Yurie Nakaya, Alberto Molano, Edward Dy, Mariano Esteban, Dolores Rodríguez, Juan Ramón Rodríguez, Peter Palese, Adolfo García-Sastre, Ruth S Nussenzweig.   

Abstract

We immunized mice with an attenuated (cold-adapted) influenza virus followed by an attenuated vaccinia virus (modified vaccinia virus Ankara), both expressing a CD8(+)-T-cell epitope derived from malaria sporozoites. This vaccination regimen elicited high levels of protection against malaria. This is the first time that the vaccine efficacy of a recombinant cold-adapted influenza virus vector expressing a foreign antigen has been evaluated.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14557672      PMCID： PMC229373          DOI： 10.1128/jvi.77.21.11859-11866.2003

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  33 in total

Review 1.  Induction of CD8+ T cells using heterologous prime-boost immunisation strategies.

Authors:  J Schneider; S C Gilbert; C M Hannan; P Dégano; E Prieur; E G Sheu; M Plebanski; A V Hill
Journal:  Immunol Rev       Date:  1999-08       Impact factor: 12.988

2.  Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen.

Authors:  O Bruña-Romero; G González-Aseguinolaza; J C Hafalla; M Tsuji; R S Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

Review 3.  Viral vectors as potential HIV-1 vaccines.

Authors:  M J Schnell
Journal:  FEMS Microbiol Lett       Date:  2001-06-25       Impact factor: 2.742

4.  Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

Authors:  R R Amara; F Villinger; J D Altman; S L Lydy; S P O'Neil; S I Staprans; D C Montefiori; Y Xu; J G Herndon; L S Wyatt; M A Candido; N L Kozyr; P L Earl; J M Smith; H L Ma; B D Grimm; M L Hulsey; J Miller; H M McClure; J M McNicholl; B Moss; H L Robinson
Journal:  Science       Date:  2001-04-06       Impact factor: 47.728

Review 5.  A striking property of recombinant poxviruses: efficient inducers of in vivo expansion of primed CD8(+) T cells.

Authors:  F Zavala; M Rodrigues; D Rodriguez; J R Rodriguez; R S Nussenzweig; M Esteban
Journal:  Virology       Date:  2001-02-15       Impact factor: 3.616

6.  Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes.

Authors:  Sarah C Gilbert; Jörg Schneider; Carolyn M Hannan; Jiang Ting Hu; Magdalena Plebanski; Robert Sinden; Adrian V S Hill
Journal:  Vaccine       Date:  2002-01-15       Impact factor: 3.641

7.  Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial.

Authors:  K A Bojang; P J Milligan; M Pinder; L Vigneron; A Alloueche; K E Kester; W R Ballou; D J Conway; W H Reece; P Gothard; L Yamuah; M Delchambre; G Voss; B M Greenwood; A Hill; K P McAdam; N Tornieporth; J D Cohen; T Doherty
Journal:  Lancet       Date:  2001-12-08       Impact factor: 79.321

8.  Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR.

Authors:  O Bruña-Romero; J C Hafalla; G González-Aseguinolaza; G Sano; M Tsuji; F Zavala
Journal:  Int J Parasitol       Date:  2001-11       Impact factor: 3.981

9.  ELISPOT assay to measure antigen-specific murine CD8(+) T cell responses.

Authors:  L H Carvalho; J C Hafalla; F Zavala
Journal:  J Immunol Methods       Date:  2001-06-01       Impact factor: 2.303

10.  Enhanced CD8+ T cell response to HIV-1 env by combined immunization with influenza and vaccinia virus recombinants.

Authors:  R M Gonzalo; D Rodríguez; A García-Sastre; J R Rodríguez; P Palese; M Esteban
Journal:  Vaccine       Date:  1999-02-26       Impact factor: 3.641
View more
  17 in total

Review 1.  Enhancing poxvirus vectors vaccine immunogenicity.

Authors:  Juan García-Arriaza; Mariano Esteban
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity.

Authors:  Zhu-Nan Li; Scott N Mueller; Ling Ye; Zhigao Bu; Chinglai Yang; Rafi Ahmed; David A Steinhauer
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Adjuvant-like effect of vaccinia virus 14K protein: a case study with malaria vaccine based on the circumsporozoite protein.

Authors:  Aneesh Vijayan; Carmen E Gómez; Diego A Espinosa; Alan G Goodman; Lucas Sanchez-Sampedro; Carlos Oscar S Sorzano; Fidel Zavala; Mariano Esteban
Journal:  J Immunol       Date:  2012-05-21       Impact factor: 5.422

4.  Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection.

Authors:  Yasushi Miyahira; Yasuhiro Takashima; Seiki Kobayashi; Yasunobu Matsumoto; Tsutomu Takeuchi; Mutsuko Ohyanagi-Hara; Ayako Yoshida; Akihiko Ohwada; Hisaya Akiba; Hideo Yagita; Ko Okumura; Hideoki Ogawa
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

5.  Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria.

Authors:  Nathan W Schmidt; Rebecca L Podyminogin; Noah S Butler; Vladimir P Badovinac; Brad J Tucker; Keith S Bahjat; Peter Lauer; Arturo Reyes-Sandoval; Claire L Hutchings; Anne C Moore; Sarah C Gilbert; Adrian V Hill; Lyric C Bartholomay; John T Harty
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-09       Impact factor: 11.205

6.  Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines.

Authors:  Qing He; Luis Martinez-Sobrido; Francis O Eko; Peter Palese; Adolfo Garcia-Sastre; Deborah Lyn; Daniel Okenu; Claudiu Bandea; Godwin A Ananaba; Carolyn M Black; Joseph U Igietseme
Journal:  Immunology       Date:  2007-04-23       Impact factor: 7.397

7.  Induction of cellular immune responses to simian immunodeficiency virus gag by two recombinant negative-strand RNA virus vectors.

Authors:  Yurie Nakaya; Takaaki Nakaya; Man-Seong Park; Jerome Cros; Jiro Imanishi; Peter Palese; Adolfo García-Sastre
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 8.  Next generation: tuberculosis vaccines that elicit protective CD8+ T cells.

Authors:  Samuel M Behar; Joshua S M Woodworth; Ying Wu
Journal:  Expert Rev Vaccines       Date:  2007-06       Impact factor: 5.217

9.  Importance of the Immunodominant CD8+ T Cell Epitope of Plasmodium berghei Circumsporozoite Protein in Parasite- and Vaccine-Induced Protection.

Authors:  Matthew P Gibbins; Katja Müller; Maya Glover; Jasmine Liu; Elyzana D Putrianti; Karolis Bauza; Arturo Reyes-Sandoval; Kai Matuschewski; Olivier Silvie; Julius Clemence R Hafalla
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

10.  Identification of targets of CD8⁺ T cell responses to malaria liver stages by genome-wide epitope profiling.

Authors:  Julius Clemence R Hafalla; Karolis Bauza; Johannes Friesen; Gloria Gonzalez-Aseguinolaza; Adrian V S Hill; Kai Matuschewski
Journal:  PLoS Pathog       Date:  2013-05-09       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.